SCHEMBL5255659

SCHEMBL5255659

COC(=O)c1sc(-c2ccc(Cl)cc2)nc1N

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.57
MAPT P10636 7/20 0.57
RAB9A P51151 5/20 0.57
KDM4E B2RXH2 4/20 0.57
NPC1 O15118 4/20 0.57
CASP3 P42574 2/20 0.57
SENP8 Q96LD8 2/20 0.57
SENP7 Q9BQF6 2/20 0.57
SENP6 Q9GZR1 2/20 0.57
ALDH1A1 P00352 4/20 0.56
GAA P10253 1/20 0.56
PKM P14618 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
POLB P06746 1/20 0.54
TRPM8 Q7Z2W7 2/20 0.53
CDC7 O00311 1/20 0.53
DBF4 Q9UBU7 1/20 0.53
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5192927 0.87 KDM4E (0.57) SMN1; SMN2MAPTRAB9AKDM4ENPC1
SCHEMBL10237187 0.85 SMN1; SMN2 (0.57) SMN1; SMN2MAPTRAB9AKDM4ENPC1
SCHEMBL1726531 0.85 TRPM8 (0.71) SMN1; SMN2MAPTKDM4ENPC1ALDH1A1
SCHEMBL8339292 0.84 SMN1; SMN2 (0.72) SMN1; SMN2MAPTRAB9AKDM4ENPC1
SCHEMBL12475892 0.82 SMN1; SMN2 (0.53) SMN1; SMN2MAPTRAB9AKDM4ENPC1
SCHEMBL12475644 0.81 SMN1; SMN2 (0.52) SMN1; SMN2MAPTRAB9AKDM4ENPC1
SCHEMBL12475538 0.81 PTPN11 (0.60) SMN1; SMN2MAPTRAB9AKDM4ENPC1
SCHEMBL12475505 0.81 SMN1; SMN2 (0.52) SMN1; SMN2MAPTRAB9AKDM4ENPC1
SCHEMBL12475391 0.80 PTPN11 (0.56) SMN1; SMN2MAPTRAB9AKDM4ENPC1
SCHEMBL12475654 0.79 PTPN11 (0.53) SMN1; SMN2MAPTRAB9AKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285557-B2 Pyrimidinones as melanin concentrating hormone receptor 1 SMITHKLINE BEECHAM P.L.C. (GB) 2007-10-23 US disclosed
US-7285557-B2 Pyrimidinones as melanin concentrating hormone receptor 1 SMITHKLINE BEECHAM P.L.C. (GB) 2007-10-23 US disclosed
US-7285557-B2 Pyrimidinones as melanin concentrating hormone receptor 1 SMITHKLINE BEECHAM P.L.C. (GB) 2007-10-23 US disclosed
EP-1442025-B1 PYRIMIDINONES AS MELANIN CONCENTRATING HORMONE RECEPTOR 1 SMITHKLINE BEECHAM PLC (GB) 2007-03-07 EP disclosed
EP-1442025-B1 PYRIMIDINONES AS MELANIN CONCENTRATING HORMONE RECEPTOR 1 SMITHKLINE BEECHAM PLC (GB) 2007-03-07 EP disclosed
US-20040220404-A1 Pyrimidinones as melanin concentrating hormone receptor 1 SMITHKLINE BEECHAM P.L.C. (GB) 2004-11-04 US disclosed
EP-1442025-A1 PYRIMIDINONES AS MELANIN CONCENTRATING HORMONE RECEPTOR 1 SMITHKLINE BEECHAM PLC (GB) 2004-08-04 EP disclosed
WO-2003033476-A1 PYRIMIDINONES AS MELANIN CONCENTRATING HORMONE RECEPTOR 1 SMITHKLINE BEECHAM PLC (GB) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040220404-A1 Pyrimidinones as melanin concentrating hormone receptor 1 MC1R, MCHR1, MCHR2 SMN1; SMN2 2043/4885MAPT 2954/4885RAB9A 1491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.